vinpocetine has been researched along with Hearing Loss in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nekrassov, V; Sitges, M | 3 |
3 other study(ies) available for vinpocetine and Hearing Loss
Article | Year |
---|---|
Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine.
Topics: 4-Aminopyridine; Acoustic Stimulation; Animals; Anticonvulsants; Auditory Threshold; Carbamazepine; Disease Models, Animal; Drug Interactions; Evoked Potentials, Auditory; Guinea Pigs; Hearing Loss; Male; Psychoacoustics; Seizures; Time Factors; Vinca Alkaloids | 2008 |
Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Convulsants; Electroencephalography; Epilepsy; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing; Hearing Loss; Male; Neuroprotective Agents; Pentylenetetrazole; Vinca Alkaloids | 2004 |
Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing.
Topics: 4-Aminopyridine; Animals; Drug Interactions; Electroencephalography; Epilepsy; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing; Hearing Loss; Male; Nootropic Agents; Olivary Nucleus; Potassium Channel Blockers; Reaction Time; Vinca Alkaloids | 2004 |